Literature DB >> 6407393

Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin.

D L Winslow, J Damme, E Dieckman.   

Abstract

Penicillins are considered to be the drugs of choice for the treatment of listeric meningitis, and relapse of infection is rare when treatment is given in appropriate doses for at least 14 days. Despite this, in vitro studies by others have shown that penicillins are bacteriostatic against Listeria spp. We have shown that thienamycin, penicillin G, and ampicillin are the most active beta-lactam antibiotics against Listeria spp. Of 10 strains tested, 9 were killed by less than or equal to 8 micrograms of beta-lactam antibiotics (greater than or equal to 99.9% killing) when subcultures were performed after 48, rather than 24, h of incubation. In contrast, chloramphenicol, erythromycin, doxycycline, and rifampin were bacteriostatic after 48 h of incubation. In time-kill curves, these last drugs antagonized the bactericidal action of penicillins. In view of the inefficiency of opsonization in the cerebrospinal fluid, these antagonistic combinations should probably be avoided in documented or suspected listeric meningitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407393      PMCID: PMC184700          DOI: 10.1128/AAC.23.4.555

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Listeriosis complicating malignant disease. A new association.

Authors:  D B Louria; T Hensle; D Armstrong; H S Collins; A Blevins; D Krugman; M Buse
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

2.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

3.  Quantitative relationships of the fourth complement component in human cerebrospinal fluid.

Authors:  J L Cova; R P Propp; K D Barron
Journal:  J Lab Clin Med       Date:  1977-03

4.  Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes.

Authors:  R C Gordon; F F Barrett; D J Clark
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

5.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

6.  Meningitis due to Listeria monocytogenes. A review of 25 cases.

Authors:  A Lavetter; J M Leedom; A W Mathies; D Ivler; P F Wehrle
Journal:  N Engl J Med       Date:  1971-09-09       Impact factor: 91.245

7.  Ampicillin treatment of listeriosis.

Authors:  R C Gordon; F F Barrett; M D Yow
Journal:  J Pediatr       Date:  1970-12       Impact factor: 4.406

8.  Listeroisis in immunosuppressed patients. A cluster of eight cases.

Authors:  N M Gantz; R L Myerowitz; A A Medeiros; G F Carrera; R E Wilson; T F O'Brien
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

9.  Antibiotic synergism against Listeria monocytogenes.

Authors:  R C Moellering; G Medoff; I Leech; C Wennersten; L J Kunz
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

10.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

View more
  22 in total

Review 1.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Antibiotic efficacy is linked to bacterial cellular respiration.

Authors:  Michael A Lobritz; Peter Belenky; Caroline B M Porter; Arnaud Gutierrez; Jason H Yang; Eric G Schwarz; Daniel J Dwyer; Ahmad S Khalil; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

Review 3.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes.

Authors:  A Boisivon; C Guiomar; C Carbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  Lack of synergism of ampicillin and gentamicin in experimental listeriosis.

Authors:  H Hof; H Gückel
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

7.  Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.

Authors:  Gitte M Knudsen; Yin Ng; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

Review 8.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

9.  Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp.

Authors:  S R Preblud; C J Gill; J M Campos
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

Review 10.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.